Mohamed Elsayed (Alsayed)

 Lead the international RWE and medical evidence portfolio across 20+ markets, driving evidence generation strategies and healthcare data capabilities.  Build and implement International RWD Strategy and Toolkit to accelerate feasibility assessments and data partnerships.

 Managed RWE initiatives and clinical research activities across GCC and MEA, strengthening regional evidence-generation capabilities.  Partnered with ministries, regulators, payers, and healthcare stakeholders to develop evidence frameworks supporting decision-making.  Supported GCC HTA readiness and development of RWE roadmaps aligned with future healthcare vision priorities.  Enhanced regional research infrastructure through collaboration with internal and external stakeholders.

 Managed Gulf-wide clinical trials and Real-World Evidence studies across Oncology, CVRM, and Respiratory therapeutic areas.  Led clinical research compliance, GCP/GVP governance, safety oversight, and study quality management.  Developed the Gulf Publication Excellence Tool to improve publication planning and research visibility.  Coached research teams and supported capability development across clinical research functions. 

 Managed clinical research operations, including clinical project execution, SFDA and IRB approvals, budgeting, and CRA oversight.  Directed multi-centre Oncology and CVRM studies while supporting regulatory submissions and local publication activities.  Coordinated research stakeholders to ensure successful study delivery and compliance.

 Managed Saudi-based Phase III/IV clinical trials and Non-Interventional Studies (NIS), ensuring compliance with SFDA requirements and IRB standards.  Supported pharmacovigilance activities, patient safety processes, and investigator training initiatives.  Managed trial documentation, site coordination, and regulatory compliance activities.